These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36129038)

  • 21. HCV Screening and Treatment Uptake Among Patients in HIV Care During 2014-2015.
    Radwan D; Cachay E; Falade-Nwulia O; Moore RD; Westergaard R; Mathews WC; Aberg J; Cheever L; Gebo KA;
    J Acquir Immune Defic Syndr; 2019 Apr; 80(5):559-567. PubMed ID: 30649030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies.
    Shimada S; Ivanics T; Kitajima T; Shamaa T; Rizzari M; Collins K; Yoshida A; Abouljoud M; Moonka D; Zhang J; Lu M; Nagai S
    Transpl Infect Dis; 2022 Apr; 24(2):e13808. PubMed ID: 35157334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic decompensation in patients with HIV/Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV) triple infection versus HIV/HCV coinfection and the effect of anti-HBV nucleos(t)ide therapy.
    Lo Re V; Wang L; Devine S; Baser O; Olufade T
    Clin Infect Dis; 2014 Oct; 59(7):1027-31. PubMed ID: 24944235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing a Surveillance-Based Approach to Create a Statewide Viral Clearance Cascade for Hepatitis C Among People With HIV and HCV Coinfection in Connecticut.
    Wegener M; Brooks R; Speers S; Nichols L; Villanueva M
    Public Health Rep; 2024; 139(2):208-217. PubMed ID: 37232422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
    Zuckerman AD; Douglas A; Whelchel K; Choi L; DeClercq J; Chastain CA
    PLoS One; 2019; 14(11):e0225434. PubMed ID: 31751399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012-2018.
    Cotte L; Hocqueloux L; Lefebvre M; Pradat P; Bani-Sadr F; Huleux T; Poizot-Martin I; Pugliese P; Rey D; Cabié A;
    Clin Infect Dis; 2021 Nov; 73(9):e3266-e3274. PubMed ID: 33400777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.
    Stafford KA; Rikhtegaran Tehrani Z; Saadat S; Ebadi M; Redfield RR; Sajadi MM
    Medicine (Baltimore); 2017 Jun; 96(26):e7348. PubMed ID: 28658155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIV.
    Hosseini-Hooshyar S; Martinello M; Yee J; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle JS; Shaw D; Hellard M; Petoumenos K; Carson J; Dore GJ; Matthews GV;
    AIDS; 2020 Jul; 34(9):1347-1358. PubMed ID: 32590433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.
    Young J; Wang S; Lanièce Delaunay C; Cooper CL; Cox J; Gill MJ; Hull M; Walmsley S; Wong A; Klein MB;
    Int J Drug Policy; 2023 Apr; 114():103981. PubMed ID: 36893502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.
    Drozd DR; Kitahata MM; Althoff KN; Zhang J; Gange SJ; Napravnik S; Burkholder GA; Mathews WC; Silverberg MJ; Sterling TR; Heckbert SR; Budoff MJ; Van Rompaey S; Delaney JAC; Wong C; Tong W; Palella FJ; Elion RA; Martin JN; Brooks JT; Jacobson LP; Eron JJ; Justice AC; Freiberg MS; Klein DB; Post WS; Saag MS; Moore RD; Crane HM
    J Acquir Immune Defic Syndr; 2017 Aug; 75(5):568-576. PubMed ID: 28520615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
    Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
    Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
    Mocroft A; Lundgren J; Gerstoft J; Rasmussen LD; Bhagani S; Aho I; Pradier C; Bogner JR; Mussini C; Uberti Foppa C; Maltez F; Laguno M; Wandeler G; Falconer K; Trofimova T; Borodulina E; Jevtovic D; Bakowska E; Kase K; Kyselyova G; Haubrich R; Rockstroh JK; Peters L;
    Clin Infect Dis; 2020 May; 70(10):2131-2140. PubMed ID: 31504296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
    Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
    Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
    Monin MB; Ingiliz P; Lutz T; Scholten S; Cordes C; Martínez-Rebollar M; Spinner CD; Nelson M; Rausch M; Bhagani S; Peters L; Reiberger T; Mauss S; Rockstroh JK; Boesecke C;
    Clin Infect Dis; 2023 Feb; 76(3):e607-e612. PubMed ID: 36004410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
    Nikolaichuk M; Mocroft A; Wandeler G; Szlavik J; Gottfredsson M; Reikvam DH; Svedhem V; Elinav H; Laguno M; Mansinho K; Devitt E; Chkhartishvili N; Behrens G; Bogner J; Viard JP; Winston A; Benfield T; Leen C; Fursa O; Rockstroh J; Peters L;
    HIV Med; 2023 Feb; 24(2):224-230. PubMed ID: 35934954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief Report: Insomnia and Risk of Myocardial Infarction Among People With HIV.
    Luu BR; Nance RM; Delaney JAC; Ruderman SA; Heckbert SR; Budoff MJ; Mathews WC; Moore RD; Feinstein MJ; Burkholder GA; Mugavero MJ; Eron JJ; Saag MS; Kitahata MM; Crane HM; Whitney BM
    J Acquir Immune Defic Syndr; 2022 May; 90(1):50-55. PubMed ID: 35001042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.
    Virlogeux V; Zoulim F; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
    BMC Med; 2017 Dec; 15(1):217. PubMed ID: 29249202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.